[Comparison of the anti-arrhythmia activity of novocainamide and obzidan in patients with ventricular extrasystole].
Comparative efficiency of obsidan, novocainamide and placebo was studied in patients with ventricular extrasystole of varying origins. Obsidan administered in a dose providing a beta-blocking effect is no less effective than novocainamide in terms of antiarrhythmic activity. Owing to this level of efficiency, obsidan can be recommended for long-term treatment of ventricular extrasystole.